OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development
Otávio de Melo Espíndola, Carlos Otávio Brandão, Yago Côrtes Pinheiro Gomes, et al.
International Journal of Infectious Diseases (2020) Vol. 102, pp. 155-162
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
Bing Sun, Norina Tang, Michael J. Peluso, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 386-386
Open Access | Times Cited: 172

Cerebrospinal fluid in COVID-19: A systematic review of the literature
Ariane Lewis, Jennifer Frontera, Dimitris G. Placantonakis, et al.
Journal of the Neurological Sciences (2021) Vol. 421, pp. 117316-117316
Open Access | Times Cited: 161

Autoimmune complications of COVID‐19
Niloufar Yazdanpanah, Nima Rezaei
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 54-62
Open Access | Times Cited: 149

Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients
Joanna Hellmuth, T. Allen Barnett, Breton M. Asken, et al.
Journal of NeuroVirology (2021) Vol. 27, Iss. 1, pp. 191-195
Open Access | Times Cited: 129

Prevalence, clinical characteristics and outcomes of Guillain−Barré syndrome spectrum associated with COVID‐19: A systematic review and meta‐analysis
Lina Palaiodimou, Maria‐Ioanna Stefanou, Aristeidis H. Katsanos, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 10, pp. 3517-3529
Open Access | Times Cited: 110

COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction
Yan‐Ting Chen, Wenren Yang, Feng Chen, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 86

The multifaceted role of neurofilament light chain protein in non-primary neurological diseases
Samir Abu‐Rumeileh, Ahmed Abdelhak, Matteo Foschi, et al.
Brain (2022) Vol. 146, Iss. 2, pp. 421-437
Open Access | Times Cited: 82

Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID‐19 and associated with neurological symptoms and disease severity
Johan Virhammar, Anja Nääs, David Fällmar, et al.
European Journal of Neurology (2020) Vol. 28, Iss. 10, pp. 3324-3331
Open Access | Times Cited: 134

COVID-19 and Alzheimer’s Disease
Marcello Ciaccio, Bruna Lo Sasso, Concetta Scazzone, et al.
Brain Sciences (2021) Vol. 11, Iss. 3, pp. 305-305
Open Access | Times Cited: 102

Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019
Otávio de Melo Espíndola, Yago Côrtes Pinheiro Gomes, Carlos Otávio Brandão, et al.
Annals of Neurology (2021) Vol. 89, Iss. 5, pp. 1041-1045
Open Access | Times Cited: 80

Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients
Rebecca De Lorenzo, Nicola Ivan Lorè, Annamaria Finardi, et al.
Journal of Neurology (2021) Vol. 268, Iss. 12, pp. 4436-4442
Open Access | Times Cited: 79

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients
Steven T. DeKosky, Patrick M. Kochanek, Alex B. Valadka, et al.
Journal of Neurotrauma (2020) Vol. 38, Iss. 1, pp. 1-43
Open Access | Times Cited: 77

Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm
Maria A. Garcia, Paula Barreras, Allie Lewis, et al.
Journal of the Neurological Sciences (2021) Vol. 427, pp. 117517-117517
Open Access | Times Cited: 64

Encephalitis in Patients with COVID-19: A Systematic Evidence-Based Analysis
Md Asiful Islam, Cinzia Cavestro, Sayeda Sadia Alam, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2575-2575
Open Access | Times Cited: 61

Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 47

Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
Grace Kenny, Liam Townsend, Stefano Savinelli, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 36

Neurological manifestation in COVID-19 disease with neuroimaging studies.
Sadegh Ghaderi, Mahsa Olfati, Majid Ghaderi, et al.
PubMed (2023) Vol. 12, Iss. 2, pp. 42-84
Closed Access | Times Cited: 26

SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature
Yumin Wang, Yanchao Wang, Liang Huo, et al.
Journal of Neurology (2021) Vol. 269, Iss. 3, pp. 1071-1092
Open Access | Times Cited: 52

Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review
Abu Baker Sheikh, Prabal Chourasia, Nismat Javed, et al.
Journal of Neuroimmunology (2021) Vol. 355, pp. 577577-577577
Open Access | Times Cited: 46

The 2022 Lady Estelle Wolfson lectureship on neurofilaments
Axel Petzold
Journal of Neurochemistry (2022) Vol. 163, Iss. 3, pp. 179-219
Open Access | Times Cited: 31

Neurological complications after COVID-19: A narrative review
Ghazale Molaverdi, Zahra Kamal, Mahshid Safavi, et al.
eNeurologicalSci (2023) Vol. 33, pp. 100485-100485
Open Access | Times Cited: 17

COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
Narjes Baazaoui, Khalid Iqbal
Journal of Alzheimer s Disease (2022) Vol. 88, Iss. 2, pp. 399-416
Open Access | Times Cited: 26

Herpesvirus and neurological manifestations in patients with severe coronavirus disease
Vanessa Cristine de Souza Carneiro, Soniza Vieira Alves‐Leon, Dmitry José de Santana Sarmento, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 26

Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19
Daniel Adesse, Luis Gladulich, Liandra Alvarez-Rosa, et al.
Fluids and Barriers of the CNS (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 23

Review of Neurological Manifestations of SARS-CoV-2
Priyal Priyal, Vineet Sehgal, Saniya Kapila, et al.
Cureus (2023)
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top